Insider Transactions in Q2 2024 at Bio Atla, Inc. (BCAB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.72%
|
$2,181
$1.37 P/Share
|
|
Jun 30
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$572
$1.37 P/Share
|
|
Jun 13
2024
|
Lawrence Steinman |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+23.09%
|
-
|
|
Jun 13
2024
|
Scott Andrew Smith |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+5.14%
|
-
|
|
Jun 13
2024
|
Sylvia Mcbrinn |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+31.65%
|
-
|
|
Jun 13
2024
|
Mary Ann Gray |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+23.44%
|
-
|
|
Jun 13
2024
|
Susan Moran |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+36.42%
|
-
|
|
Jun 13
2024
|
Eddie Williams |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+31.02%
|
-
|
|
May 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.75%
|
$2,181
$1.51 P/Share
|
|
May 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$572
$1.51 P/Share
|
|
Apr 30
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.75%
|
$4,362
$2.26 P/Share
|
|
Apr 30
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$1,144
$2.26 P/Share
|